At the news
? BEARISHIMPACT 6/10 PRESS-RELEASE filed Mar 24, 2026 at 21:53 ET
Apogee Therapeutics priced an underwritten public offering of 5,000,000 shares at $70.00 per share, raising approximately $350 million in gross proceeds. The company also granted underwriters a 30-day option to purchase up to an additional 750,000 shares. The offering is expected to close on March 26, 2026, subject to customary conditions.
- Apogee Therapeutics is offering 5,000,000 shares of common stock at $70.00 per share.
- Gross proceeds from the offering are expected to be approximately $350 million.
- Underwriters have a 30-day option to purchase up to an additional 750,000 shares.
- The offering is expected to close on March 26, 2026, subject to customary closing conditions.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access